Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 41, Issue 3, Pages 522-528Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/03639045.2014.884117
Keywords
Inhalation; poly(D, L lactide-co-glycolide); porous microspheres; solvent evaporation; water-in-oil-in-water
Categories
Funding
- 3M Healthcare Ltd, Morley Street, Loughborough, Leicestershire
Ask authors/readers for more resources
The effect of suspension stabilizers, internal aqueous phase volume and polymer amount were investigated for the production of protein loaded poly(D, L lactide-co-glycolide) ( PLGA) microparticles suitable for pulmonary drug delivery. PLGA microparticles were produced adopting water-in-oil-in-water (W/O/W) solvent evaporation technique and were investigated for surface morphology, particle size, encapsulation efficiency (EE%) and in-vitro release profile. Porous surface morphologies with a narrow size distribution were observed when employing 0.5 ml internal aqueous phase; 23.04 mu m (+/- 0.98), 15.05 mu m (+/- 0.27) and 22.89 mu m (+/- 0.41) for PVA, Tween 80 and oleic acid. Porous microparticles exhibited increased size and reduction in EE% with increasing internal aqueous phase, with non-porous microparticles produced when adopting 2.0 ml internal aqueous phase. The selection of stabilizer influences the size of the pores formed thus offers potential for the aerodynamic properties of the microparticles to be manipulated to achieve suitable aerosolization characteristics for pulmonary delivery of proteins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available